PREVENTIONGENETICS INC.

In News

What to know about Exact Sciences. The Madison company was sold to Abbottfor $23 billion. - Milwaukee Journal Sentinel

Milwaukee Journal Sentinel - Nov 20, 2025

Exact Sciences Acquires PreventionGenetics to Accelerate Availability of Hereditary Cancer Testing for More Patients - PR Newswire

PR Newswire - Jan 09, 2022

PreventionGenetics Assumes the Management of Sponsored Genetic Testing Program for Three Rare Genetic Diseases: Acute Hepatic Porphyria, Primary Hyperoxaluria Type 1 & Hereditary ATTR Amyloidosis - Business Wire

Business Wire - Mar 13, 2025

Exact Sciences makes $190 million acquisition, enters licensing agreement - In Business Madison

In Business Madison - Jan 11, 2022

Rare Disease Genetic Testing Market Size | CAGR Of 13.1% - Market.us

Market.us - Apr 18, 2023

EXACT SCIENCES CORP SEC 10-K Report - TradingView

TradingView - Feb 13, 2026

Vigil Neuroscience Launches ALSPAware to Provide Access to - globenewswire.com

globenewswire.com - May 08, 2023

Rare Disease Genetic Testing Market Size Report 2026-2033 - Grand View Research

Grand View Research - Jun 01, 2020

Exact Sciences (EXAS) Stock Price, News & Analysis - Stock Titan

Stock Titan - Apr 24, 2025

Leadership Marshfield Council announces 2019-20 selections - Hub City Times

Hub City Times - Sep 06, 2019

PreventionGenetics Leaps Ahead With PGxome™ Custom Panels - PR Newswire

PR Newswire - Mar 14, 2017

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment